BOWIE, Md., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Inovalon (Nasdaq: INOV), a leading technology company providing advanced, cloud-based platforms empowering data-driven healthcare, today announced the names of local and national charitable organizations the …
DENVER , Jan. 03, 2019 (GLOBE NEWSWIRE) -- Elixinol, a wholly owned subsidiary of Elixinol Global (EXL) (ASX: EXL; OTC: ELLXF), announces Joy Beckerman’s appointment to Elixinol’s team starting January 1, 2019. In Beckerman’s role as Regulatory Officer and …
DORADO, Puerto Rico, Jan. 03, 2019 (GLOBE NEWSWIRE) -- GSRX Industries Inc. (OTCQB: GSRX) (“GSRX” or, the “Company”) announced today that it will report fourth quarter and annual 2018 financial and operating results on February 28, 2019. About GSRX …
NEW YORK, Jan. 03, 2019 (GLOBE NEWSWIRE) -- Oculogica, Inc., a pioneer in algorithm-based neuro-diagnostics, announced that the U.S. Food and Drug Administration (FDA) granted their De Novo request for the commercialization of EyeBOX®, the first non- …
SUNNYVALE, Calif., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Ondas Holdings Inc. (OTCQB: ONDS) announced today that it intends to conduct a private placement offering for up to $25 million of its common stock (the “Offering”). The Company intends to use the net …
SOUTH SAN FRANCISCO, Calif., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral diseases …
Dublin, Jan. 03, 2019 (GLOBE NEWSWIRE) -- The "China Online Gaming Market, Number of Users, Category (Mobile, PC Online Client Games, Web), Market based on Age Group, Segments & Companies" report has been added to ResearchAndMarkets.com's …
Amerigo Resources Ltd. (TSX:ARG) VANCOUVER, BRITISH COLUMBIA, CANADA, January 3, 2019 /EINPresswire.com/ -- January 3, 2019 N.R. 2019-01 Amerigo’s MVC Phase Two Expansion Meets Completion Criteria Vancouver, British Columbia – January 3, 2019/ …
NEW YORK, Jan. 03, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Biohaven Pharmaceutical Holding …
SAN DIEGO, Jan. 03, 2019 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company focused on the development of precision medicines for oncology, today announced its participation at the 37th Annual J.P. Morgan …
DALLAS, TX, Jan. 03, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- NaturalShrimp, Inc. (OTCQB: SHMP) is pleased to announce that NaturalShrimp and F&T Water Solutions, LLC have received U.S. Patent No. 10,163,199 B2 for the Recirculating Aquaculture …
Study will provide the first randomized, controlled efficacy and safety data of every-six-week dosing for natalizumab CAMBRIDGE, Mass., Jan. 03, 2019 (GLOBE NEWSWIRE) -- The first patient has been enrolled in a global Phase 3b study evaluating the efficacy …
PARSIPPANY, N.J., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) today reported preliminary unaudited EXPAREL® (bupivacaine liposome injectable suspension) net product sales of $94 million for the fourth quarter of 2018 and $ …
VANCOUVER, British Columbia, Jan. 03, 2019 (GLOBE NEWSWIRE) -- Amerigo Resources Ltd. ("Amerigo" or the "Company") (TSX: ARG) is pleased to announce that Minera Valle Central (“MVC”), the Company’s 100% owned operation located near …
HOUSTON, Jan. 03, 2019 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company focused on the development of oncology drug candidates, all of which are based on …
TORONTO, Jan. 03, 2019 (GLOBE NEWSWIRE) -- Fairfax Financial Holdings Limited (TSX: FFH and FFH.U) announces that it has declared a dividend of US$10.00 per share on its outstanding multiple voting and subordinate voting shares, payable on January 28, 2019 …
TORONTO, Jan. 03, 2019 (GLOBE NEWSWIRE) -- Gran Colombia Gold Corp. (TSX: GCM; OTCQX: TPRFF) announced today that its Board of Directors has adopted a shareholder rights plan agreement (the “Plan”). The Plan is effective immediately and the Toronto Stock …
MINNEAPOLIS, Jan. 03, 2019 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (“DiaMedica”) (NASDAQ:DMAC) (TSX-V:DMA) announced today that the U.S. Food and Drug Administration ("FDA") has accepted DiaMedica’s Investigational New Drug application (…
LEXINGTON, Mass., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Translate Bio (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene …
-- Received approval to begin multiple-ascending dose in Phase 1/2 clinical trial of MRT5005, an mRNA therapeutic for CF -- -- Submitted IND for Phase 1/2 clinical trial of MRT5201, an mRNA therapeutic for OTC deficiency -- LEXINGTON, Mass., Jan. 03, 2019 …
07 days 01:59:41
